Keyword: Novartis

News

Novartis Takes Gyroscope Therapeutics for $1.5 Billion

22.02.2022 -

Swiss pharma Novartis has acquired Gyroscope Therapeutics, a clinical-stage gene therapy company focused on diseases of the eye, from Syncona, a UK-based firm that says...

News

Private Equity Buyers Seen as Circling Sandoz

02.02.2022 -

US private equity firms Blackstone and Carlyle may make a joint offer for the Novartis generics unit Sandoz, Bloomberg reports. With six other possible bidders seen as...

News

Novartis May Have Sandoz Buyer on the Hook

14.12.2021 -

Novartis and market watchers alike have been dropping repeated hits that a sale of the Swiss drugs giant’s Sandoz-branded generic drugs arm may be closer than has been...

News

Novartis Selling Roche Shares Back to Swiss Rival

08.11.2021 -

In the reverse of a deal sealed 20 years ago, Novartis is selling the 33% stake it bought in Roche back to the compatriot drugmaker. The latest transaction between the...

News

Novartis Reviewing Options for Sandoz

27.10.2021 -

Swiss drugs giant Novartis has launched a strategic review to decide what to do with the generics business it operates under the name Sandoz – not coincidentally the name...

News

Novartis Boosts Ophthalmology with Arctos Medical Buy

30.09.2021 -

Swiss drugmaker Novartis has acquired Arctos Medical, a compatriot start-up developing optogenetic therapies. Financial terms of the deal were not disclosed.

News

The Transition to Digitalization in the Pharmaceutical Industry

15.09.2021 -

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...

News

Expert Statement: Markus Zeitz, Novartis

06.09.2021 -

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...